http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003504332-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-343
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2000-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2003-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2003504332-A
titleOfInvention How to treat mental disorders
abstract (57) [Summary]nThe present invention relates to the use of escitalopram (S-(+)-enantiomer of citalopram) or a pharmaceutically acceptable salt thereof for anxiety, especially systemic and social anxiety disorders, posttraumatic stress disorders, obsessive-compulsive disorders. And a method for use in the manufacture of a medicament useful for treating psychiatric disorders, including panic attacks.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009519969-A
priorityDate 1999-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002524510-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002531556-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H04244024-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0015220-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0236177-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426266256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507269
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493337
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2771
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29922413
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547315

Total number of triples: 34.